Here is the synopsis of our sample research paper on Health Care Providers: Winners and Losers. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 39 page paper providing Chapters 2 and 3 of a larger work assessing winners and losers in the health care wars. Care providers and health care plans constantly are at odds, providers wanting to charge increased rates and plans seeking to hold costs steady. The purpose here is to assess which contingent loses more, which is a difficult call. No one – neither care providers, premium-paying employers, care plans nor end consumers is satisfied with the structure of health care as it currently exists. The paper reviews several lawsuits between providers, plans and patients; discusses the origins of the current financial and delivery mess; and reviews proposed solutions by Harvard’s Michael Porter and Clayton Christensen. Bibliography lists 22 sources.
Page Count:
39 pages (~225 words per page)
File: CC6_KShlthCaWinLos.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
One of the reasons that the current crisis has been so long in building - and in addressing - is that there are so many interlaced, interconnected factors affecting
the total industry. Virtually the only "winner" currently reasonably assured of continued success is the pharmaceutical industry, and that assurance is only fleeting. Big pharma is accused of
gouging everyone - patients, physicians, insurers and now even Medicare - and evidence consisting of a single tablet costing the consumer more than $1 each provides a compelling argument.
A factor generally not discussed, however, is the process that a drug developer must go through to gain approval for use by the Food and Drug Administration (FDA). It
can cost billions to bring a new drug to market, and the developer has patent protection only for relatively few years. To recoup its investment in the drug and
to generate revenues to use in the research and development of new products, pharmaceutical companies are faced with the unpleasant task of pricing their products well above where users and
sellers of the products would prefer to see them priced. The issue of drug costs falls outside the cost factors being considered here,
however. This investigation is concerned more with the dynamics between payers, providers and consumers. Has government healthcare policy played are role in the open market?
Government health care policy not only has played a role in the open market, it has determined what that "open market" will be. Medicare was born
of noble ideas and certainly retains a place in the health care of the nations elderly, disabled and indigent. It has come to control all of U.S. health care,
...